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We need more prospective studies for 
Kounis syndrome
To the Editor: We read the article[1] about Kounis syndrome 
published in an earlier issue of your journal with great interest. 
This letter is intended both to correct a mistake in the article and to 
emphasise its importance by sharing our own clinical experiences.
Kounis syndrome, which is a myocardial ischaemia picture 
accompanying allergic cases, was first described in 1991.[2] Though not 
rare, Kounis syndrome is among the diseases less commonly found 
in literature, and one of the least known and most underdiagnosed 
diseases by clinicians.[3] Actual incidence of the disease is not exactly 
known, because of poor reliability in reporting and misdiagnosis.[3,4]
The incidence of the disease was indicated to be between 4.3 and 
9.6 per 100 000 in retrospective studies.[5,6] Only one study shows 
the prospective incidence of Kounis syndrome,[3,7] conducted in our 
institution. In this study, Akoz et al.[7] found the incidence of the disease 
to be 19.4/100 000.[7] This incidence is high compared with retrospective 
studies, indicating that the syndrome is actually more common than 
estimated. Unfortunately, this prospective study was mistakenly stated to 
be retrospective in the letter published in your journal.[1]
Although Kounis syndrome is found in all races and age groups 
across the world,[1] the number of the reported cases from southern 
European countries is relatively high.[5] Factors such as genetic 
predisposition, similar climatic and environmental conditions, 
inaccuracies in drug use and higher clinician awareness of the disease 
in that region may contribute to the differences in geographical 
distribution.[5] With this letter, we particularly want to thank the 
respected scientist Dr Kounis, who contributed to awareness of the 
syndrome among clinicians. Along with an increase in publications 
about Kounis syndrome, it is possible that there will be an increase 
in reported cases of the disease in African countries. Symptoms 
and/or findings of systemic allergic response accompanying 
electrocardiographic or laboratory findings of myocardial ischaemia 
should remind us of the possibility of Kounis syndrome.[8] However, 
sometimes Kounis syndrome can be observed without classic clinical 
findings of hypersensitivity such as skin lesion (urticaria, angio-
oedema, mucosal involvement) or hypotension.[7]
The diagnosis of the syndrome is made primarily via symptoms 
and signs, electrocardiographic and laboratory features, and echo-
cardiographic and angiographic changes in patients.[3] Our prospec-
tive study showed that cardiac magnetic resonance imaging (MRI) 
can also be used as an alternative to these methods,[7] especially in 
patients who have contrast allergy or who need to be careful about 
radiation exposure. Cardiac MRI is successful in the early diagno-
sis of the syndrome, making the disease diagnosable in individuals 
whose electrocardiogram and troponin are normal, distinguishing 
between ischaemic and non-ischaemic cases.[7] Although cardiac 
MRI use is not common in emergency services, we want to remind 
again that it has a place in the diagnosis of Kounis syndrome.
There are three variants of Kounis syndrome, depending on 
whether there is a lesion in the coronary artery or if there is a drug-
eluting stent in the patient.[3] In the treatment stage, although there 
are some differences in the variants, it is difficult to know which 
exact type of Kounis syndrome the patient has during the first 
evaluation of an individual at emergency services. Thus, early patient 
treatment should include management of acute coronary syndrome 
and alleviation of the allergic symptoms.[9]
In conclusion, we believe that doctors in Africa will increasingly 
diagnose Kounis syndrome in the future, as current experience in 
dark-skinned patients is very low.
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